Synthesis and in vitro evaluation of the farnesyltransferase inhibitor 
pepticinnamin E

Hinterding, K; Hagenbuch, P; Retey, J; Waldmann, Herbert

doi:10.1002/(SICI)1521-3765(19990104)5:1<227::AID-CHEM227>3.0.CO;2-X

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Synthesis and in vitro evaluation of the farnesyltransferase inhibitor pepticinnamin E

MPS-Authors

/persons/resource/persons98735

Waldmann, Herbert
Abt. IV: Chemische Biologie, Max Planck Institute of Molecular Physiology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Hinterding, K., Hagenbuch, P., Retey, J., & Waldmann, H. (1999). Synthesis and in vitro evaluation of the farnesyltransferase inhibitor pepticinnamin E. CHEMISTRY-A EUROPEAN JOURNAL, 5(1), 227-236. doi:10.1002/(SICI)1521-3765(19990104)5:1<227:AID-CHEM227>3.0.CO;2-X.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0014-7130-0

Abstract

The farnesyltransferase inhibitor pepticinnamin E was synthesized and shown to have the S configuration at the central, non-proteinogenic amino acid. Using a recombinant yeast farnesyltransferase the biological activity of the natural product and structural analogues was determined. It was shown that pepticinnamin E is a bisubstrate inhibitor. Furthermore, several structural parameters were identified that decisively influence inhibition of the farnesyl transfer.